Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India

Surgery

Volumn 149, Issue 1, 2011, Pages 126-134

  Gangwar, Ruchika ^a   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CISPLATIN; CYCLOOXYGENASE 2; GEMCITABINE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TUBERCULOSIS;

AGE DISTRIBUTION; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; INDIA; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 78650170738     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.04.004     Document Type: Article

References (32)

1. L.S. Freedman, B.K. Edwards, L.A.G. Ries, J.L. Young, A.S. Ibrahim, and H.M. Khaled Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEER. National Cancer Institute. Urinary bladder cancer MECC monograph 11 2006 97 109
2. T. Hla, D. Bishop-Bailey, C.H. Liu, H.J. Schaefers, and O.C. Trifan Cyclooxygenase-1 and -2 isoenzymes Int J Biochem Cell Biol 31 1999 551 557 (Pubitemid 29219401)
3. Y.I. Cha, and R.N. DuBois NSAIDs and cancer prevention: targets downstream of COX-2 Annu Rev Med 58 2007 239 252 (Pubitemid 46706512)
4. A. Greenhough, H.J. Smartt, A.E. Moore, H.R. Roberts, A.C. Williams, and C. Paraskeva The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 2009 377 386
5. R. Tazawa, X.M. Xu, K.K. Wu, and L.H. Wang Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene Biochem Biophys Res Commun 203 1994 190 199 (Pubitemid 24281079)
6. T. Kosaka, A. Miyata, H. Ihara, S. Hara, T. Sugimoto, and O. Takeda Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2 Eur J Biochem 221 1994 889 897 (Pubitemid 24146188)
7. G. Singh-Ranger, and K. Mokbel The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition Eur J Surg Oncol 28 2002 729 737 (Pubitemid 36240572)
8. K. Uefuji, T. Ichikura, H. Mochizuki, and N. Shinomiya Expression of cyclooxygenase-2 protein in gastric adenocarcinoma J Surg Oncol 69 1998 168 172 (Pubitemid 28549893)
9. R.C. Panguluri, L.O. Long, W. Chen, S. Wang, A. Coulibaly, and F. Ukoli COX-2 gene promoter haplotypes and prostate cancer risk Carcinogenesis 25 2004 961 966 (Pubitemid 38886082)
10. C.M. Ulrich, J. Whitton, J.H. Yu, J. Sibert, R. Sparks, and J.D. Potter PTGS2(COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs Cancer Epidemiol Biomarkers Prev 14 2005 616 619 (Pubitemid 40489204)
11. A. Papafili, M.R. Hill, D.J. Brull, R.J. McAnulty, R.P. Marshall, and S.E. Humphries Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arterioscler Thromb Vasc Biol 22 2002 1631 1636
12. X. Zhang, X. Miao, W. Tan, B. Ning, Z. Liu, and Y. Hong Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 2005 565 576 (Pubitemid 41096644)
13. S.J. Cok, and A.R. Morrison The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency J Biol Chem 276 2001 23179 23185
14. M. Colombel, M. Soloway, and H. Akaza Epidemiology, staging, grading and risk stratification of bladder cancer Eur Urol Suppl 7 2008 618 626
15. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1998 1215
16. S. Schneider, D. Roessli, and L. Excoffier Arlequin ver. 2.00. Software for population genetics data analysis 2000 Genetics and Biometry Laboratory, University of Geneva Geneva, Switzerland
17. P. Larsson, H. Wijkstrom, A. Thorstenson, J. Adolfsson, U. Norming, and P. Wiklund A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years Scand J Urol Nephrol 37 2003 195 201 (Pubitemid 36791815)
18. U. Vogel, J. Christensen, H. Wallin, S. Friis, B.A. Nexø, and O. Raaschou-Nielsen Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study Mutat Res 639 2008 89 100
19. X. Zhang, X. Miao, W. Tan, B. Ning, Z. Liu, and Y. Hong Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 2005 565 576 (Pubitemid 41096644)
20. M. Sanak, W. Szczeklik, and A. Szczeklik Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma J Allergy Clin Immunol 116 2005 221 223 (Pubitemid 40909772)
21. H. Ben Nasr, K. Chahed, N. Bouaouina, and L. Chouchane PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma Mol Biol Rep 36 2009 193 200
22. Y. Mizutani, H. Nakanishi, Y.N. Li, N. Sato, A. Kawauchi, and T. Miki Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522 J Urol 172 2004 1474 1479 (Pubitemid 39249752)
23. S. Kang, Y.B. Kim, M.H. Kim, K.S. Yoon, J.W. Kim, and N.H. Park Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer Cancer Lett 217 2005 11 16 (Pubitemid 39642861)
24. R. Upadhyay, M. Jain, S. Kumar, U.C. Ghoshal, and B. Mittal Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma Mut Res 663 2009 52 59
25. Z. Hu, X. Miao, H. Ma, X. Wang, W. Tan, and Q. Wei A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population Lung Cancer 48 2005 11 17 (Pubitemid 40380996)
26. J. Stocks, D. Bradbury, L. Corbett, L. Pang, and A.J. Knox Cytokines upregulate vascular endothelial growth factor secretion by human airway smooth muscle cells: Role of endogenous prostanoids FEBS Lett 579 2005 2551 2556 (Pubitemid 40615657)
27. T. Aoki, Y. Nagakawa, A. Tsuchida, K. Kasuya, K. Kitamura, and K. Inoue Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors Oncol Rep 9 2002 761 765
28. L.M. Moons, E.J. Kuipers, A.M. Rygiel, A.Z. Groothuismink, H. Geldof, and W.A. Bode COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma Am J Gastroenterol 102 2007 2373 2379 (Pubitemid 47631756)
29. P. Boffetta Tobacco smoking and risk of bladder cancer Scand J Urol Nephrol Suppl 218 2008 45 54
30. M.J. Khoury, and W.D. Flanders Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls Am J Epidemiol 144 1996 207 213 (Pubitemid 26313497)
31. L.W. Chang, Y.C. Chang, C.C. Ho, M.H. Tsai, and P. Lin Increase of carcinogenic risk via enhancement of cyclooxygenase-2 expression and hydroxyestradiol accumulation in human lung cells as a result of interaction between BaP and 17-beta estradiol Carcinogenesis 28 2007 1606 1612 (Pubitemid 47241812)
32. R. Adam Cyclooxygenase-2 in transitional cell carcinoma - a legitimate target? J Urol 177 2007 818 819 (Pubitemid 46216407)